Skip to main content Skip to footer
Circe
  • Home
  • About
  • Community
    • Breast cancer
    • Colorectal Cancer
    • Cervical cancer
    • Endometrial cancer
    • Ovarian cancer
    • Patient Organizations
  • Collaboration
  • Research
  • News
  • Contact
  • Home
  • About
  • Community
    • Breast cancer
    • Colorectal Cancer
    • Cervical cancer
    • Endometrial cancer
    • Ovarian cancer
    • Patient Organizations
  • Collaboration
  • Research
  • News
  • Contact
Lund University

Cervical cancer

Cervical cancer develops in the cervix, the lower part of the uterus, and is usually caused by a persistent HPV (human papillomavirus) infection, a common sexually transmitted virus. There are two main types: Squamous cell carcinoma (most common) and Adenocarcinoma (less common). The disease usually develops gradually from precancerous changes that can be detected and treated early.

Risk factors

The main cause of cervical cancer is persistent HPV infection. Other factors that may increase risk include:

  • Early exposure to HPV
  • Smoking
  • Weakened immune system
  • Low screening participation

Screening and early detection

Cervical cancer is one of the few cancers where effective prevention and early detection is possible.

In Sweden:

  • HPV vaccination is offered as part of the national vaccination program
  • The vaccine protects against the most common types of HPV that cause cervical cancer
  • Vaccination works best when given before exposure to HPV, but can still provide protection if given later in life
  • All women are invited to regular cervical screening (HPV test/cell sampling)

Together, HPV vaccination and participation in screening provide strong protection against cervical cancer and have already led to a significant reduction in cases in Sweden.

Early-stage cervical cancer often causes no symptoms, which makes screening especially important.

Possible symptoms include:

  • Abnormal vaginal bleeding (e.g. after intercourse or between periods)
  • Unusual vaginal discharge
  • Pelvic pain or discomfort during intercourse

Diagnosis and treatment

If cervical cancer is suspected, an investigation is carried out to confirm the diagnosis and determine the stage of the disease.

This may include:

  • Gynecological examination
  • Cell sampling (HPV test/Pap test)
  • Biopsy
  • Imaging tests to assess spread

In Sweden, patients are managed through standardized care pathways (SVF) to ensure timely diagnosis and coordinated care.

Treatment options may include:

  • Surgery, often used in early-stage cancer
  • Radiotherapy, sometimes combined with chemotherapy
  • Chemotherapy, particularly advanced cases

Living with and beyond cervical cancer

Many people recover from cervical cancer, especially when diagnosed early. With increasing survival, more people are living with and beyond the disease.

Recovery is a continuous process, and people may experience:

  • Physical effects, such as fatigue, pain, or treatment-related side effects
  • Emotional challenges, including anxiety or fear of recurrence
  • Changes in daily life and sexual health

In Sweden, support is available throughout the cancer journey:

  • Follow-up care through specialist healthcare teams
  • Access to a contact nurse (kontaktsjuksköterska) for guidance and coordination
  • Cancer rehabilitation services, supporting physical, emotional, and social
  • recovery
  • Psychological support and patient organizations, offering peer support and
  • practical advice

With the right support, many people are able to return to everyday life and maintain a good quality of life.

Fertility and family planning

Cervical cancer often affects people of reproductive age, making fertility an important consideration. Treatment may affect fertility in different ways:

  • Surgery may involve removing the cervix or uterus
  • Radiotherapy can affect the ovaries and uterus, impacting the ability to become pregnant
  • Some treatments may lead to early menopause

Fertility-preserving treatment options may be possible in early stages. In Sweden, fertility counselling is part of cancer care, and decisions are made together with a multidisciplinary care team to balance effective treatment with future reproductive goals.

Reducing inequalities in cervical cancer care

Cervical cancer is largely preventable, but differences in access to HPV vaccination, screening, and follow-up care can lead to unequal outcomes.

Key factors include:

  • Participation in screening programs, which is essential for early detection
  • Access to HPV vaccination, which protects against most cervical cancers
  • Health literacy and awareness, influencing when people seek care
  • Socioeconomic and cultural factors, including barriers related to income, education, or language

In Sweden, efforts to reduce inequalities include:

  • Organized screening programs with regular invitations
  • National HPV vaccination programs
  • Increasing use of self-sampling for HPV testing to improve access

Key Facts

  • In Sweden, around 500–600 women are diagnosed each year
  • It can affect younger and middle-aged women
  • Most cases are caused by HPV infection
  • Most cervical cancers can be prevented through HPV vaccination and screening
  • Globally, it remains a common cancer, especially where screening is limited
  • Survival rates are high when the disease is detected early

Support and Resources

  • Gyncancerförbundet
    Sweden’s national organization for people affected by gynecological cancers, offering information, peer support, local activities, and advocacy for patients and families.
  • Nätverket mot gynekologisk cancer

    A non-profit network that provides information about gynecological cancers and works to improve prevention, diagnosis, treatment, rehabilitation, and patient rights.

  • Cancerfonden – Cervical Cancer

    Provides reliable information about cervical cancer, including risk factors, symptoms, diagnosis, treatment, rehabilitation, and support.

  • 1177 Vårdguiden

    Sweden’s national healthcare information service, offering evidence-based information about cervical cancer, screening, HPV vaccination, treatment, and available healthcare services.

CirceLund University
  • Home
  • About
  • Community
    • Breast cancer
    • Colorectal Cancer
    • Cervical cancer
    • Endometrial cancer
    • Ovarian cancer
    • Patient Organizations
  • Collaboration
  • Research
  • News
  • Contact

Advancing women’s cancer research through collaboration, innovation, and equity

Founding grant support:

circecenter@med.lu.se

Tel: + 46 (0)46 222 0365

Lund University, CIRCE

Scheelevägen 2, MV-404-B2

223 81 Lund, Sweden

© 2026 CIRCEcenter.org. All rights reserved.
Designed by Clavis Communications